NEW YORK, March 22, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Analysis of European Biosimilars Market http://www.reportlinker.com/p0803069/Analysis-of-European-Biosimilars-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Generic_Drug
The aim of this research study is to thoroughly assess and analyse the biosimilars market, as well as market and technology trends in Europe, in order to provide strategic recommendations for the success of market participants. This study is focused on established segments in Europe including Erythropoietin, Granulocyte Colony Stimulating Factors, Human Growth Hormones and emerging segments including monoclonal antibodies, Insulin and interferon. The established market segments consist of products currently approved and marketed in Europe. New therapeutic classes of drugs are expected to be a major contributor in the emerging market segments.
Table of Contents
Executive Summary 21
Executive Summary 22
Market Definitions 24
Market Segmentation 25
Geographic Segmentation 26
Executive Summary Market Engineering Measurements 27
Executive Summary CEO's Perspective 29
Total Biosimilars Market 30
Market Overview Key Questions This Study Will Attempt to Answer 31
Market Overview 32
Total Biosimilars Market Regional Overview 34
Forecast and Trends Global Biosimilars Market 36
Forecast Assumptions 37
Market Engineering Measurements 38
Total Biosimilars Market Revenue Forecast 39
Market Share and Competitive Analysis Total Biosimilars Market 41
Market Share Companies (Global) 42
European Biosimilars Market 44
Market Overview European Biosimilars 45
Industry Challenges 47
Key Industry Challenges 48
External Challenges: Drivers and Restraints European Biosimilars Market 52
Drivers and Restraints 53
European Biosimilars Market Impact Mapping of Drivers and Restraints 58
Forecast and Trends European Biosimilars Market 59
Market Engineering Measurements 60
Europe Biosimilars Market Revenue Forecast 61
Market Trends European Biosimilars 63
European Biosimilars Market Impact Assessment of Top Trends 64
Demand Analysis European Biosimilars Market 65
European Biosimilars Market Comparative Analysis: Generics, Biosimilars and Biologics 66
Biosimilars Market Analysis 67
European Biosimilars Market Biosimilar Pricing Analysis 68
European Biosimilars Market PESTLE Analysis 70
Market Share and Competitive Analysis European Biosimilars Market 71
Segment Breakdown Europe 72
European Biosimilars Segment Market Share Analysis 73
European Biosimilars Companies Market Share Analysis 74
Competitive Environment 76
Competitive Landscape Analysis European Biosimilars Companies 77
Competitive Landscape Analysis 78
Competitive Landscape Analysis Biosimilars Characteristics 87
Regulatory Guidelines European Biosimilars Market 91
Biosimilars Regulatory Guidelines 92
European Erythropoietin Biosimilars Market 93
Market Overview European Erythropoietin Biosimilars 94
Forecast and Trends European Erythropoietin Biosimilars Market 95
Market Engineering Measurements 96
European Erythropoietin Biosimilars Market Revenue Forecast 97
Market Share and Competitive Analysis European Erythropoietin Biosimilars Market 99
Erythropoietin Biosimilars Market Analysis 100
Erythropoietin Biosimilars Market Share Analysis 102
Competitive Landscape European Erythropoietin Biosimilars 104
Regulatory Guidelines European Erythropoietin Biosimilars Market 106
EMEA Guidelines Biosimilar Erythropoietin 107
European Granulocyte Colony Stimulating Factors Biosimilars Market 109
Market Overview European Granulocyte Colony Stimulating Factors Biosimilars 110
Forecast and Trends European Granulocyte Colony Stimulating Factors Biosimilars Market 111
Market Engineering Measurements 112
Granulocyte Colony Stimulating Factor Biosimilars Market Revenue Forecast 113
Market Share and Competitive Analysis European Granulocyte Colony Stimulating Factors Biosimilars Market 115
Granulocyte Colony Stimulating Factors Biosimilars Market Analysis 116
Granulocyte Colony Stimulating Factors Biosimilars Market Share Analysis 117
Competitive Landscape European Granulocyte Colony Stimulating Factors Biosimilars 119
Regulatory Guidelines European Granulocyte Colony Stimulating Factors Biosimilars Market 121
EMEA Guidelines Biosimilar Granulocyte Colony Stimulating Factors 122
European Human Growth Hormone Biosimilars Market 124
Market Overview European Human Growth Hormone Biosimilars 125
Forecast and Trends European Human Growth Hormone Biosimilars Market 126
Market Engineering Measurements 127
Human Growth Hormone Biosimilars Market Revenue Forecast 128
Market Share and Competitive Analysis European Human Growth Hormone Biosimilars Market 130
Human Growth Hormone Biosimilars Market Analysis 131
Competitive Landscape European Human Growth Hormone Biosimilars 132
Regulatory Guidelines European Human Growth Hormone Biosimilars Market 133
EMEA Guidelines Biosimilar Human Growth Hormone 134
Key Emerging Biosimilars in Europe: Monoclonal Antibodies 136
Market Overview European Monoclonal Antibodies Biosimilars 137
Market Analysis European Monoclonal Antibodies Biosimilars Market 138
Monoclonal Antibodies Biosimilars Market Analysis 139
Regulatory Guidelines European Monoclonal Antibodies Biosimilars Market 140
EMEA Guidelines Biosimilar Monoclonal Antibodies 141
Key Emerging Biosimilars in Europe: Insulin 143
Market Overview European Insulin Biosimilars 144
Market Analysis European Insulin Biosimilars Market 145
Insulin Biosimilars Market Analysis 146
Regulatory Guidelines European Insulin Biosimilars Market 147
EMEA Guidelines Biosimilar Insulin 148
Key Emerging Biosimilars in Europe: Interferon 150
Market Overview European Interferon Biosimilars 151
Market Analysis European Interferon Biosimilars Market 152
Interferon Biosimilars Market Analysis 153
Regulatory Guidelines European Interferon Biosimilars Market 155
EMEA Guidelines Biosimilar Interferon 156
Regional Analysis of European Biosimilars Market The United Kingdom 159
Biosimilars Market Overview The United Kingdom 160
Forecast and Trends The United Kingdom Biosimilars Market 161
Market Engineering Measurements 162
The United Kingdom Biosimilars Market Revenue Forecast 163
Biosimilars Market Germany 165
Biosimilars Market Overview Germany 166
Forecast and Trends Germany Biosimilars Market 167
Market Engineering Measurements 168
Germany Biosimilars Market Revenue Forecast 169
Biosimilars Market France 171
Biosimilars Market Overview France 172 Forecast and Trends France Biosimilars Market 173
Market Engineering Measurements 174
French Biosimilars Market Revenue Forecast 175 Biosimilars Market Italy 177
Biosimilars Market Overview Italy 178
Forecast and Trends Italy Biosimilars Market 179
Market Engineering Measurements 180
Italian Biosimilars Market Revenue Forecast 181
Biosimilars Market Spain 183
Biosimilars Market Overview Spain 184
Forecast and Trends Spain Biosimilars Market 185
Market Engineering Measurements 186
Spanish Biosimilars Market Revenue Forecast 187
Biosimilars Market Benelux 189
Biosimilars Market Overview Benelux 190
Forecast and Trends Benelux Biosimilars Market 191
Market Engineering Measurements 192
Benelux Biosimilars Market Revenue Forecast 193
Biosimilars Market Scandinavia 195
Biosimilars Market Overview Scandinavia 196
Forecast and Trends Scandinavia Biosimilars Market 197
Market Engineering Measurements 198
Scandinavian Biosimilars Market Revenue Forecast 199
Product Profiling 201
Product Profiling Biosimilars in Europe 202
Product Profiling Biologics 203
Future Landscape Analysis 206
Conclusions and Strategic Recommendations 208
Biosimilars Market Key Success Factors 209
Biosimilars Market Manufacturing Strategies 210
Biosimilars Market Commercialisation Strategies 211
Conclusions 212
The Last Word 213
Appendix 216
Biotech Companies 217
Government R&D Expenditure in Biotechnology 218
Pharmaceutical R&D Expenditure 219
Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market 220
Government Healthcare Expenditure 221
Abbreviations 222
Market Engineering Methodology 223
List of FiguresBiosimilars Market: Manufacturing and Development Process for Generics, Biosimilars and Biologics (Europe), 2010 33Total Biosimilars Market: Company Market Share Analysis of Top 4 Participants (Global), 2010 43Biosimilars Market: Time from Marketing Authorisation to Price Approval (Europe), 2010 68Biosimilars Market: Market Share Analysis of Segments (Europe), 2010 73Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010 75Biosimilars Market: Competitive Structure (Europe), 2010 76Erythropoietin Biosimilars Market: Retail Analysis (Europe), 2010 101Erythropoietin Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010 103Granulocyte Colony Stimulating Factor Biosimilars Market: Company Market Share Analysis of Market Participants (Europe), 2010 118Decision Support Database: Biotech Companies (Western Europe), 2002-2012 217Decision Support Database: Government R&D Expenditure in Biotechnology (Western Europe), 2002-2012 218Decision Support Database: Pharmaceutical R&D Expenditure (Western Europe), 2002-2012 219Decision Support Database: Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market (Western Europe), 2002-2012 220Decision Support Database: Government Healthcare Expenditure (Western Europe), 2002-2012 221
List of Charts
Biosimilars Market: Market Segmentation (Europe), 2010 25
Biosimilars Market: Geographic Segmentation (Europe), 2010 26
Biosimilars Market: Market Engineering Measurements (Europe), 2010 27
Total Biosimilars Market: Market Share Percent by Country (Global), 2010 34
Total Biosimilars Market: Market Engineering Measurements (Global), 2010 38
Total Biosimilars Market: Revenue Forecast (Global), 2008-2017 39
Toatl Biosimilars Market: Company Market Share by Revenues (Global), 2010 42
Biosimilars Market: Key Stake Holders (Europe), 2010 45
Biosimilars Market: Key Industry Challenges (Europe), 2011-2017 48
Biosimilars Market: Key Market Drivers and Restraints (Europe), 2011-2017 53
European Biosimilars Market: Impact Mapping of Drivers and Restraints (Europe), 2011-2017 58
Biosimilars Market: Market Engineering Measurements (Europe), 2010 60
Biosimilars Market: Revenue Forecast (Europe), 2008-2017 61
Biosimilars Market: Impact Assessment of Top Trends (Europe), 2010 64
Biosimilars Market: Pricing Analysis (Europe), 2010 69
Biosimilars Market: PESTLE Analysis (Europe), 2010 70
Biosimilars Market: Market Share Percent by Segment (Europe), 2010 72
Biosimilars Market: Company Market Share by Revenues (Europe), 2010 74
Erythropoietin Biosimilars Market: Market Engineering Measurements (Europe), 2010 96
Erythropoietin Biosimilars Market: Revenue Forecast (Europe), 2008-2017 97
Erythropoietin Biosimilars Market: Market Share Percent by Companies (Europe), 2010 102
Granulocyte Colony Stimulating Factors Biosimilars Market: Market Engineering Measurements (Europe), 2010 112
Granulocyte Colony Stimulating Biosimilars Market: Revenue Forecast (Europe), 2008-2017 113
Granulocyte Colony Stimulating Biosimilars Market: Market Share Percent by Companies (Europe), 2010 117
Human Growth Hormone Biosimilars Market: Market Engineering Measurements (Europe), 2010 127
Human Growth Hormone Biosimilars Market: Revenue Forecast (Europe), 2008-2017 128
Biosimilars Market: Market Engineering Measurements (The United Kingdom), 2010 162
Biosimilars Market: Revenue Forecast (The United Kingdom), 2008-2017 163
Biosimilars Market: Market Engineering Measurements (Germany), 2010 168
Biosimilars Market: Revenue Forecast (Germany), 2008-2017 169
Biosimilars Market: Market Engineering Measurements (France), 2010 174
Biosimilars Market: Revenue Forecast (France), 2008-2017 175
Biosimilars Market: Market Engineering Measurements (Italy), 2010 180
Biosimilars Market: Revenue Forecast (Italy), 2008-2017 181
Biosimilars Market: Market Engineering Measurements (Spain), 2010 186
Biosimilars Market: Revenue Forecast (Spain), 2008-2017 187
Biosimilars Market: Market Engineering Measurements (Benelux), 2010 192
Biosimilars Market: Revenue Forecast (Benelux), 2008-2017 193
Biosimilars Market: Market Engineering Measurements (Benelux), 2010 192
Biosimilars Market: Revenue Forecast (Benelux), 2008-2017 193
Biosimilars Market: Market Engineering Measurements (Scandinavia), 2010 198
Biosimilars Market: Revenue Forecast (Scandinavia), 2008-2017 199
To order this report: Generic Drug Industry: Analysis of European Biosimilars Market
Check our Industry Analysis and Insights
Contact:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article